Brown recluse spider envenomation: A prospective trial of hyperbaric oxygen therapy

Academic Emergency Medicine

Volumn 4, Issue 3, 1997, Pages 184-192

  Maynor, Michael L ^a,b   Moon, Richard E ^a   Klitzman, Bruce ^a   Fracica, Philip J ^a   Canada, Andrew ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

brown recluse; envenomation; HBO; hyperbaric oxygen therapy; spider bite; wound healing

Indexed keywords

SNAKE VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HYPERBARIC OXYGEN; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; SKIN BLOOD FLOW; SKIN MANIFESTATION; SPIDER BITE; TREATMENT OUTCOME; WOUND HEALING;

EID: 0031058576     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.1997.tb03738.x     Document Type: Article

References (43)

1. Wong RC, Hughes SE, Voorhees JJ. Spider biles: review in depth. Arch Dermatol. 1987; 123:98-103.
2. Edwards JJ, Anderson RL. Loxoscelism of the eyelid. Arch Ophthalmol. 1980; 98:1997-2000.
3. Binder LS. Acute arthropod envenomation: incidence, clinical features and management. Med Toxicol Adverse Drug Exp. 1989; 4:163-73.
4. Hobbs GD, Jarrell RE. Brown recluse spider bites: a common cause of necrotic arachnidism. Am J Emerg Med. 1989; 7:309-12.
5. Svendsen FJ. Treatment of clinically diagnosed brown recluse spider bites with hyperbaric oxygen; a clinical observation. J Ark Med Soc. 1986; 83:199-204.
6. Kendall TE, Caniglia RJ. Hyperbaric oxygen in the treatment of clinically diagnosed brown recluse spider bites: a review of 48 cases [abstract]. Undersea Biomed Res. 1989; 16:21.
7. Maynor ML, Abt JL, Osborne P. Brown recluse spider bites: beneficial effects of hyperbaric oxygen. J Hyperbar Med. 1992; 7:89-102.
8. Strain GM, Snider TG, Tedford BL, Cohn GH. Hyperbaric oxygen effects on brown recluse spider envenomation in rabbits. Toxicon. 1991; 29: 989-96
9. Phillips S, Kohn M, Baker D, et al. Therapy of brown spider envenomation: a controlled trial of hyperbaric oxygen, dapsone, and cyproheptadine. Ann Emerg Med. 1995; 25:363-8.
10. Auer AL, Hershey FB. Surgery for necrotic bites of the brown spider. Arch Surg. 1974; 108:612-8.
11. Kensler T, Egner P, Moore G, Taffe BG, Twerdok LE, Trush MA. Role of inflammatory cells in the metabolic activation of polycyclic aromatic hydrocarbons in mouse skin [abstract]. Toxicol Appl Pharmacol. 1987; 90:337.
12. Suzuki K, Ota H, Sasagawa S, Sakalani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem. 1983; 132:345-52.
13. Bradley PB, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982; 78:206-9.
14. Smith JK, Grisham MB, Granger DN, Korthuis J. Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Circ Res. 1990; 66:789-93.
15. Carden DL, Smith JK, Korthuis RJ. Neutrophil-mediated microvascular dysfunction in postischemic canine skeletal muscle. Circ Res. 1990; 66:1436-43.
16. Ekstrom T, Garberg P, Egestad B, Hogberg J Recovery of malondialdehyde in urine as a 2,4 dinitrophenylhydrazine derivative analyzed with high-performance liquid chromatography. Chem Biol Interact. 1988; 66:177-87.
17. Lee HS, Csallany AS. Measurement of free and bound malondialdehyde in vitamin E deficient and supplemented rat liver tissues. Lipids. 1987; 22.104-7.
18. Rees RS, Nanney LB, Yates RA, King LE. Interaction of brown recluse spider venom on cell membranes: the inciting mechanism? J Invest Dermatol. 1984; 83:270-5.
19. Babcock JL, Geren CR, Civello DJ. Purification and characterization of a toxin from brown recluse spider venom gland extracts. Toxicon. 1981; 5:677-89.
20. Dressler KA, Kolesnick RN. Ceramide 1-phosphate, a novel phospholipid in human leukemia cells. J Biol Chem. 1990; 265:14917-21.
21. Forrester LJ, Barrett JT, Campbell BJ. Red blood cell lysis induced by the venom of the brown recluse spider, the role of sphingomyelinase-D. Arch Biochem Biophys. 1978; 187:355-65.
22. Geren CR, Chan TK, Ward BC, Howell DE, Pinkston K, Odell GV. Composition and properties of extract of fiddleback spider venom apparatus (L. reclusa). Toxicon. 1973; 11:471-9.
23. Heitz JR, Norment BR. Characteristics of an alkaline phosphatase activity in brown recluse venom. Toxicon. 1974; 12:181-7.
24. Geren CR, Chan TK, Howell DF, Odell GV. Partial characterization of the low molecular weight fractions of the extract of the venom apparatus of the brown recluse spider and of its hemolymph. Toxicon. 1975; 13:233-8.
25. Kurpiewski G, Forrester LJ, Barrett JT, Campbell BJ. Platelet aggregation and sphingomyelinase-D activity of a purified toxin from the venom of Loxosceles reclusa. Biochem Biophys Acta. 1981; 678:467-76.
26. Rees RD, Gates C, Timmons S, Des Prez RM, King LE. Plasma components are required for platelet activation by the toxin of Loxosceles reclusa. Toxicon. 1988; 11:1035-45.
27. Smith CW, Micks DW. The rate of polymorphonuclear leukocytes in the lesion caused by the venom of the brown spider, Loxosceles reclusa. Lab Invest. 1970; 22:90-3.
28. Geren CR, Rekow MA, Beasley JN, Jones JL. The mechanisms of action of the mammalian toxin isolated from Loxosceles reclusa venom [abstract]. Toxicon. 1988; 23:567.
29. Rees RS, Gates C. Platelet activation stimulated by the toxin of the brown recluse spider requires serum amyloid P component, not C-reactive protein. Toxicon. 1989; 27:953-4.
30. Hufford DC, Morgan PN. C-reactive protein as a mediator in the lysis of human erythrocytes sensitized by brown recluse spider venom. Proc Soc Exp Biol Med. 1981; 167:493-7.
31. Rees RS, King LE. Treatment of brown recluse spider bites. J Am Acad Dermatol. 1986; 14:691-2.
32. Fardon DW. The treatment of brown spider bites. Plast Reconstr Surg. 1967; 40:482-8.
33. Rees RS, Shack RB, Withers H, Madden JJ, Franklin JD, Lynch JB. Management of the brown recluse spider bite. Plast Reconstr Surg. 1981; 68:768-73.
34. King LE, Rees RS. Dapsone treatment of a brown recluse spider bite [abstract]. JAMA. 1983; 250:648.
35. Clark JM, Fisher AB. Oxygen toxicity and extension of tolerance in oxygen therapy. In: David JC, Hunt TK (eds). Hyperbaric Oxygen Therapy, 4th ed. Bethesda, MD: Undersea Medical Society, 1988, pp 61-77.
36. Zamboni WA, Roth AC, Russell RC, Nemiroff PM, Casas L, Smoot EC. The effect of acute HBO therapy on axial pattern skin flap survival when administered during and after total ischemia. J Reconstr Microsurg. 1989; 5:343-50.
37. Zamboni WA, Roth AC, Russell RC, Graham B, Suchy H, Kucan J. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reconstr Surg. 1993; 91:1110-23.
38. Thorn SR, Elbuken ME. Oxygen-dependant antagonism of lipid peroxidation. Free Radic Biol Med. 1991; 10:413-26.
39. Thorn SR. Functional inhibition of leukocyte 82 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats Toxicol Appl Pharmacol. 1993; 123:248-56.
40. Hunt TK, Zederfeldt B. Oxygen and healing. Am J Surg. 1969; 118:523-5.
41. Hunt TK, Pai MP. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet, 1972; 135:561-7.
42. Weiss SJ. Tissue destruction of neutrophils. N Engl J Med. 1989; 320:10-20.
43. Mader JT, Brown GL. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis. 1980; 142:918-21.